DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Ichikawa H, Sugimoto M, Sugimoto K. et al.
Rapid metabolizer genotype of CYP 2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis.

J Gastroenterol Hepatol 2016;
31: 716-726

Download Bibliographical Data

Search in:
Access: